KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a

PTEN-regulated AKT/FoxO3a/Bim signaling contributes to reactive oxygen species-mediated apoptosis in selenite-treated colorectal cancer cells

(2013) H Luo et al.   Cell Death & Disease

Activation of protein kinase CK2 attenuates FOXO3a functioning in a PML-dependent manner: implications in human prostate cancer

(2013) A Chatterjee et al.   Cell Death & Disease

Nuclear karyopherin a2: a novel biomarker for infiltrative astrocytomas

(2012) K. Gousias et al.   JOURNAL OF NEURO-ONCOLOGY

Quantitative Proteomics Reveals Regulation of Karyopherin Subunit Alpha-2 (KPNA2) and Its Potential Novel Cargo Proteins in Nonsmall Cell Lung Cancer

(2012) Chun-I Wang et al.   MOLECULAR & CELLULAR PROTEOMICS

Importin-α1 as a Novel Prognostic Target for Hepatocellular Carcinoma

(2011) Kenichiro Yoshitake et al.   ANNALS OF SURGICAL ONCOLOGY

KPNA2 Expression Is an Independent Adverse Predictor of Biochemical Recurrence after Radical Prostatectomy

(2011) A. Mortezavi et al.   CLINICAL CANCER RESEARCH

High Expression of Karyopherin-α2 Defines Poor Prognosis in Non–Muscle-Invasive Bladder Cancer and in Patients with Invasive Bladder Cancer Undergoing Radical Cystectomy

(2011) Jørgen Bjerggaard Jensen et al.   EUROPEAN UROLOGY

Karyopherin alpha7 (KPNA7), a divergent member of the importin alpha family of nuclear import receptors

(2010) Joshua B Kelley et al.   BMC CELL BIOLOGY

Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome

(2010) Chun-I. Wang et al.   INTERNATIONAL JOURNAL OF CANCER

Overexpression of Karyopherin-2 in Epithelial Ovarian Cancer and Correlation With Poor Prognosis

(2010) Min Zheng et al.   OBSTETRICS AND GYNECOLOGY

Astrocyte Elevated Gene-1 is a Novel Prognostic Marker for Breast Cancer Progression and Overall Patient Survival

(2008) J. Li et al.   CLINICAL CANCER RESEARCH

Nuclear karyopherin α2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity

(2008) Oleg Gluz et al.   INTERNATIONAL JOURNAL OF CANCER

The Karyopherin proteins, Crm1 and Karyopherin β1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation

(2008) Pauline J. van der Watt et al.   INTERNATIONAL JOURNAL OF CANCER